HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyeong-Man Kim Selected Research

Brain Diseases (Brain Disorder)

3/2020Catalpol and Mannitol, Two Components of Rehmannia glutinosa, Exhibit Anticonvulsant Effects Probably via GABAA Receptor Regulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyeong-Man Kim Research Topics

Disease

5Substance-Related Disorders (Drug Abuse)
03/2024 - 05/2013
3Schizophrenia (Dementia Praecox)
04/2021 - 01/2017
2Parkinson Disease (Parkinson's Disease)
04/2021 - 08/2007
2Nervous System Diseases (Neurological Disorders)
01/2021 - 05/2013
2Central Nervous System Diseases (CNS Diseases)
01/2017 - 11/2016
1Mental Disorders (Mental Disorder)
03/2023
1Insulin Resistance
11/2022
1Dyskinesias (Dyskinesia)
04/2021
1Seizures (Absence Seizure)
03/2020
1Epilepsy (Aura)
03/2020
1Brain Diseases (Brain Disorder)
03/2020
1Hyperprolactinemia
01/2016
1Prostatic Neoplasms (Prostate Cancer)
04/2014
1Neoplasms (Cancer)
04/2014
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2013
1Shock
01/2013
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
09/2007
1Tremor (Tremors)
09/2007
1Morphine Dependence
09/2007
1Lymphoma (Lymphomas)
01/2006
1Hypersensitivity (Allergy)
05/2004

Drug/Important Bio-Agent (IBA)

4Dopamine D3 ReceptorsIBA
01/2018 - 01/2006
3Dopamine (Intropin)FDA LinkGeneric
05/2013 - 08/2007
2LigandsIBA
03/2023 - 09/2015
2Tyrosine (L-Tyrosine)FDA Link
11/2022 - 04/2014
2Cholinergic ReceptorsIBA
04/2021 - 01/2021
2Neurotransmitter Agents (Neurotransmitter)IBA
04/2021 - 01/2017
2Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
01/2016 - 09/2007
1Controlled SubstancesIBA
03/2024
1Serotonin ReceptorsIBA
03/2023
1Cholinergic Agents (Cholinergics)IBA
04/2021
1Dopamine Receptors (Dopamine Receptor)IBA
04/2021
1Levodopa (L Dopa)FDA LinkGeneric
04/2021
1Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
04/2021
1Ligand-Gated Ion ChannelsIBA
01/2021
1catalpolIBA
03/2020
1GABA Receptors (GABA Receptor)IBA
03/2020
1Mannitol (Osmitrol)FDA LinkGeneric
03/2020
1acteosideIBA
03/2020
1StrychnineIBA
03/2020
1aucubinIBA
03/2020
1Pentylenetetrazole (Metrazol)IBA
03/2020
1GABA AntagonistsIBA
03/2020
1Anticonvulsants (Antiepileptic Drugs)IBA
03/2020
1ErbB Receptors (EGF Receptor)IBA
01/2018
1Epidermal Growth Factor (EGF)IBA
01/2017
1Dopamine Uptake Inhibitors (Dopamine Reuptake Inhibitors)IBA
11/2016
1Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2016
1Proteins (Proteins, Gene)FDA Link
04/2014
1src-Family KinasesIBA
04/2014
1CateninsIBA
04/2014
1GABA Agonists (GABA Receptor Agonists)IBA
01/2013
1GABA-A Receptors (GABA(A) Receptor)IBA
01/2013
15,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA
01/2013
1GABA-A Receptor AntagonistsIBA
01/2013
1AcidsIBA
01/2013
1gamma-Aminobutyric Acid (GABA)IBA
01/2013
1Drinking WaterIBA
01/2013
1Morphine (MS Contin)FDA LinkGeneric
09/2007
1Naloxone (Narcan)FDA LinkGeneric
09/2007
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
09/2007
1TeaIBA
09/2007
1Mating FactorIBA
01/2006
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
01/2006
1AntigensIBA
05/2004
1IgE Receptors (Fc epsilon RI)IBA
05/2004